- Vancouver Tech Journal
- Posts
- Bulletin: Despite domestic snubbing, AbCellera made nearly $200 million off of its COVID-19 treatment
Bulletin: Despite domestic snubbing, AbCellera made nearly $200 million off of its COVID-19 treatment
Plus, it generated a net profit of $119 million USD, up from a net loss of $2 million on $11.6 million in revenue.
William Johnson
March 29, 2021
Subscribe to Premium to read the rest.
Become a paying subscriber of Premium to get access to this post and other subscriber-only content.
UpgradeA subscription gets you:
- 🧠 Monthly members-only workshops and social events with investors, founders, and operators
- 🔑 Exclusive content: In-depth stories that you won’t find anywhere else
- 🗓️ 50% off all our Vancouver Tech Journal events
- 🎟 First access to events we put on
- 🔓 The Morning Report: Your members-only newsletter that contains ALL the Vancouver news this week
- ♥️ Supporting Vancouver's tech community